$34.00
In Stock
Blastovin has proven effective in the treatment of the following neoplasms, both alone and in combination with other oncolytic drugs: common malignant neoplasms: generalized Hodgkin’s disease (stage III and IV modification of the Ann Arbor rye stage system) – non-Hodgkin’s lymphoma: – reticulum sarcoma – lymphosarcoma. Neuroblastoma. Histiocytosis X. Less common malignancies: choriocarcinoma resistant to other chemotherapeutic agents. Embryonic testicular carcinoma. Breast carcinoma refractory to appropriate endocrine surgery and hormone therapy
Active ingredient: vinblastine sulfate 10 mg
Prescription medicine.
